Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir
Clinical trial NCT02249130 · COMPLETED
Trial details
- NCT number
- NCT02249130
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-03-01
- Primary completion
- 2000-04-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.